nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—Necrotizing enterocolitis—Docetaxel—stomach cancer	0.0349	0.0827	CcSEcCtD
Methotrimeprazine—Necrotising enterocolitis neonatal—Docetaxel—stomach cancer	0.0349	0.0827	CcSEcCtD
Methotrimeprazine—Necrotizing enterocolitis—Capecitabine—stomach cancer	0.0338	0.0801	CcSEcCtD
Methotrimeprazine—Necrotising enterocolitis neonatal—Capecitabine—stomach cancer	0.0338	0.0801	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Docetaxel—stomach cancer	0.0285	0.0677	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Capecitabine—stomach cancer	0.0276	0.0655	CcSEcCtD
Methotrimeprazine—Sudden death, cause unknown—Capecitabine—stomach cancer	0.0235	0.0558	CcSEcCtD
Methotrimeprazine—Necrotising colitis—Epirubicin—stomach cancer	0.0193	0.0456	CcSEcCtD
Methotrimeprazine—CHRM3—muscle of abdomen—stomach cancer	0.0183	0.146	CbGeAlD
Methotrimeprazine—Necrotising colitis—Doxorubicin—stomach cancer	0.0178	0.0422	CcSEcCtD
Methotrimeprazine—HTR2A—myenteric nerve plexus—stomach cancer	0.013	0.103	CbGeAlD
Methotrimeprazine—Photosensitivity—Floxuridine—stomach cancer	0.0115	0.0274	CcSEcCtD
Methotrimeprazine—Sudden death—Irinotecan—stomach cancer	0.0093	0.022	CcSEcCtD
Methotrimeprazine—Sudden death—Fluorouracil—stomach cancer	0.00891	0.0211	CcSEcCtD
Methotrimeprazine—HTR2A—vagus nerve—stomach cancer	0.00867	0.069	CbGeAlD
Methotrimeprazine—HTR2A—vein—stomach cancer	0.00838	0.0666	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Floxuridine—stomach cancer	0.008	0.019	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Floxuridine—stomach cancer	0.00729	0.0173	CcSEcCtD
Methotrimeprazine—Sudden death—Capecitabine—stomach cancer	0.00623	0.0148	CcSEcCtD
Methotrimeprazine—Drowsiness—Mitomycin—stomach cancer	0.00613	0.0145	CcSEcCtD
Methotrimeprazine—DRD5—hematopoietic system—stomach cancer	0.00475	0.0378	CbGeAlD
Methotrimeprazine—Sudden death—Methotrexate—stomach cancer	0.00463	0.011	CcSEcCtD
Methotrimeprazine—CHRM5—epithelium—stomach cancer	0.0039	0.031	CbGeAlD
Methotrimeprazine—Photosensitivity—Fluorouracil—stomach cancer	0.00377	0.00893	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Floxuridine—stomach cancer	0.00367	0.0087	CcSEcCtD
Methotrimeprazine—Drug interaction—Docetaxel—stomach cancer	0.00355	0.00841	CcSEcCtD
Methotrimeprazine—ADRA1D—epithelium—stomach cancer	0.00348	0.0277	CbGeAlD
Methotrimeprazine—Somnolence—Mitomycin—stomach cancer	0.00348	0.00824	CcSEcCtD
Methotrimeprazine—DRD5—lymphoid tissue—stomach cancer	0.00335	0.0266	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Docetaxel—stomach cancer	0.00329	0.0078	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Irinotecan—stomach cancer	0.00316	0.00748	CcSEcCtD
Methotrimeprazine—DRD5—endocrine gland—stomach cancer	0.00273	0.0217	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—stomach cancer	0.00266	0.0211	CbGeAlD
Methotrimeprazine—Liver injury—Epirubicin—stomach cancer	0.00264	0.00625	CcSEcCtD
Methotrimeprazine—Photosensitivity—Capecitabine—stomach cancer	0.00263	0.00624	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Fluorouracil—stomach cancer	0.00261	0.00619	CcSEcCtD
Methotrimeprazine—Jaundice—Irinotecan—stomach cancer	0.0026	0.00615	CcSEcCtD
Methotrimeprazine—Liver injury—Doxorubicin—stomach cancer	0.00244	0.00578	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Fluorouracil—stomach cancer	0.00238	0.00564	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Epirubicin—stomach cancer	0.00222	0.00526	CcSEcCtD
Methotrimeprazine—Urinary retention—Capecitabine—stomach cancer	0.0022	0.00521	CcSEcCtD
Methotrimeprazine—ADRA1D—endocrine gland—stomach cancer	0.00219	0.0174	CbGeAlD
Methotrimeprazine—ADRA1A—hematopoietic system—stomach cancer	0.00219	0.0174	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Docetaxel—stomach cancer	0.00218	0.00517	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Capecitabine—stomach cancer	0.00211	0.00501	CcSEcCtD
Methotrimeprazine—CHRM3—smooth muscle tissue—stomach cancer	0.0021	0.0167	CbGeAlD
Methotrimeprazine—Hepatocellular injury—Doxorubicin—stomach cancer	0.00205	0.00487	CcSEcCtD
Methotrimeprazine—ADRA1A—epithelium—stomach cancer	0.002	0.0159	CbGeAlD
Methotrimeprazine—Photosensitivity—Methotrexate—stomach cancer	0.00196	0.00465	CcSEcCtD
Methotrimeprazine—Weight increased—Docetaxel—stomach cancer	0.00188	0.00445	CcSEcCtD
Methotrimeprazine—Photosensitivity—Epirubicin—stomach cancer	0.00183	0.00435	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Capecitabine—stomach cancer	0.00182	0.00432	CcSEcCtD
Methotrimeprazine—Weight increased—Capecitabine—stomach cancer	0.00182	0.00431	CcSEcCtD
Methotrimeprazine—CYP1A2—hematopoietic system—stomach cancer	0.00181	0.0144	CbGeAlD
Methotrimeprazine—Jaundice—Docetaxel—stomach cancer	0.00179	0.00425	CcSEcCtD
Methotrimeprazine—Jaundice—Capecitabine—stomach cancer	0.00174	0.00412	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Docetaxel—stomach cancer	0.00172	0.00407	CcSEcCtD
Methotrimeprazine—ADRA2C—pancreas—stomach cancer	0.0017	0.0135	CbGeAlD
Methotrimeprazine—Photosensitivity—Doxorubicin—stomach cancer	0.0017	0.00402	CcSEcCtD
Methotrimeprazine—HRH1—hematopoietic system—stomach cancer	0.00169	0.0135	CbGeAlD
Methotrimeprazine—CHRM2—endocrine gland—stomach cancer	0.00168	0.0134	CbGeAlD
Methotrimeprazine—ADRA2A—hematopoietic system—stomach cancer	0.00166	0.0132	CbGeAlD
Methotrimeprazine—Agranulocytosis—Capecitabine—stomach cancer	0.00166	0.00394	CcSEcCtD
Methotrimeprazine—CHRM3—digestive system—stomach cancer	0.00166	0.0132	CbGeAlD
Methotrimeprazine—CYP2E1—hematopoietic system—stomach cancer	0.00163	0.013	CbGeAlD
Methotrimeprazine—Promethazine—HRH4—stomach cancer	0.00162	0.148	CrCbGaD
Methotrimeprazine—Tachycardia—Fluorouracil—stomach cancer	0.00159	0.00376	CcSEcCtD
Methotrimeprazine—HRH1—epithelium—stomach cancer	0.00155	0.0123	CbGeAlD
Methotrimeprazine—ADRA1A—lymphoid tissue—stomach cancer	0.00154	0.0123	CbGeAlD
Methotrimeprazine—CHRM1—endocrine gland—stomach cancer	0.00153	0.0122	CbGeAlD
Methotrimeprazine—Somnolence—Irinotecan—stomach cancer	0.00151	0.00358	CcSEcCtD
Methotrimeprazine—HRH1—smooth muscle tissue—stomach cancer	0.00149	0.0119	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Epirubicin—stomach cancer	0.00147	0.00349	CcSEcCtD
Methotrimeprazine—Constipation—Irinotecan—stomach cancer	0.00145	0.00344	CcSEcCtD
Methotrimeprazine—Somnolence—Fluorouracil—stomach cancer	0.00145	0.00343	CcSEcCtD
Methotrimeprazine—HTR2A—hematopoietic system—stomach cancer	0.00142	0.0113	CbGeAlD
Methotrimeprazine—CHRM3—endocrine gland—stomach cancer	0.00137	0.0109	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00136	0.00323	CcSEcCtD
Methotrimeprazine—Photosensitivity reaction—Methotrexate—stomach cancer	0.00136	0.00322	CcSEcCtD
Methotrimeprazine—ADRA2A—pancreas—stomach cancer	0.00136	0.0108	CbGeAlD
Methotrimeprazine—Drowsiness—Methotrexate—stomach cancer	0.00133	0.00314	CcSEcCtD
Methotrimeprazine—HTR2A—epithelium—stomach cancer	0.00129	0.0103	CbGeAlD
Methotrimeprazine—CYP2D6—hematopoietic system—stomach cancer	0.00129	0.0103	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Epirubicin—stomach cancer	0.00127	0.00301	CcSEcCtD
Methotrimeprazine—Weight increased—Epirubicin—stomach cancer	0.00127	0.003	CcSEcCtD
Methotrimeprazine—CYP1A2—digestive system—stomach cancer	0.00126	0.01	CbGeAlD
Methotrimeprazine—ADRA1A—endocrine gland—stomach cancer	0.00126	0.01	CbGeAlD
Methotrimeprazine—Chlorpromazine—HRH4—stomach cancer	0.00126	0.115	CrCbGaD
Methotrimeprazine—Hypersensitivity—Irinotecan—stomach cancer	0.00125	0.00297	CcSEcCtD
Methotrimeprazine—HTR2A—smooth muscle tissue—stomach cancer	0.00125	0.00991	CbGeAlD
Methotrimeprazine—Drowsiness—Epirubicin—stomach cancer	0.00124	0.00294	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Methotrexate—stomach cancer	0.00124	0.00293	CcSEcCtD
Methotrimeprazine—DRD2—endocrine gland—stomach cancer	0.00123	0.00981	CbGeAlD
Methotrimeprazine—Jaundice—Epirubicin—stomach cancer	0.00121	0.00287	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Fluorouracil—stomach cancer	0.0012	0.00284	CcSEcCtD
Methotrimeprazine—HRH1—digestive system—stomach cancer	0.00118	0.00937	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00118	0.00279	CcSEcCtD
Methotrimeprazine—Weight increased—Doxorubicin—stomach cancer	0.00117	0.00278	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Epirubicin—stomach cancer	0.00116	0.00275	CcSEcCtD
Methotrimeprazine—Drowsiness—Doxorubicin—stomach cancer	0.00115	0.00272	CcSEcCtD
Methotrimeprazine—CYP2E1—lymphoid tissue—stomach cancer	0.00115	0.00912	CbGeAlD
Methotrimeprazine—Tachycardia—Docetaxel—stomach cancer	0.00115	0.00272	CcSEcCtD
Methotrimeprazine—ADRA1A—liver—stomach cancer	0.00113	0.00902	CbGeAlD
Methotrimeprazine—CYP2E1—digestive system—stomach cancer	0.00113	0.00901	CbGeAlD
Methotrimeprazine—Jaundice—Doxorubicin—stomach cancer	0.00112	0.00265	CcSEcCtD
Methotrimeprazine—Tachycardia—Capecitabine—stomach cancer	0.00111	0.00263	CcSEcCtD
Methotrimeprazine—ADRA2C—liver—stomach cancer	0.00108	0.0086	CbGeAlD
Methotrimeprazine—Agranulocytosis—Doxorubicin—stomach cancer	0.00107	0.00254	CcSEcCtD
Methotrimeprazine—Somnolence—Docetaxel—stomach cancer	0.00104	0.00247	CcSEcCtD
Methotrimeprazine—CYP1A2—endocrine gland—stomach cancer	0.00104	0.00827	CbGeAlD
Methotrimeprazine—Constipation—Docetaxel—stomach cancer	0.001	0.00238	CcSEcCtD
Methotrimeprazine—HTR2A—digestive system—stomach cancer	0.000984	0.00783	CbGeAlD
Methotrimeprazine—HRH1—endocrine gland—stomach cancer	0.000974	0.00775	CbGeAlD
Methotrimeprazine—Constipation—Capecitabine—stomach cancer	0.000972	0.0023	CcSEcCtD
Methotrimeprazine—ADRA2A—endocrine gland—stomach cancer	0.000956	0.00761	CbGeAlD
Methotrimeprazine—CYP1A2—liver—stomach cancer	0.000938	0.00746	CbGeAlD
Methotrimeprazine—CYP2E1—endocrine gland—stomach cancer	0.000936	0.00744	CbGeAlD
Methotrimeprazine—CYP2D6—digestive system—stomach cancer	0.000897	0.00713	CbGeAlD
Methotrimeprazine—Hypersensitivity—Docetaxel—stomach cancer	0.000865	0.00205	CcSEcCtD
Methotrimeprazine—Clomipramine—GSTP1—stomach cancer	0.000844	0.0769	CrCbGaD
Methotrimeprazine—CYP2E1—liver—stomach cancer	0.000844	0.00671	CbGeAlD
Methotrimeprazine—Hypersensitivity—Capecitabine—stomach cancer	0.000837	0.00199	CcSEcCtD
Methotrimeprazine—ADRA2C—lymph node—stomach cancer	0.000829	0.00659	CbGeAlD
Methotrimeprazine—HTR2A—endocrine gland—stomach cancer	0.000813	0.00647	CbGeAlD
Methotrimeprazine—Tachycardia—Epirubicin—stomach cancer	0.000773	0.00183	CcSEcCtD
Methotrimeprazine—Somnolence—Methotrexate—stomach cancer	0.000752	0.00178	CcSEcCtD
Methotrimeprazine—CYP2D6—endocrine gland—stomach cancer	0.000741	0.00589	CbGeAlD
Methotrimeprazine—HTR2A—liver—stomach cancer	0.000733	0.00583	CbGeAlD
Methotrimeprazine—Tachycardia—Doxorubicin—stomach cancer	0.000715	0.00169	CcSEcCtD
Methotrimeprazine—Somnolence—Epirubicin—stomach cancer	0.000704	0.00167	CcSEcCtD
Methotrimeprazine—Acepromazine—HTR1A—stomach cancer	0.000697	0.0636	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR1A—stomach cancer	0.000681	0.0621	CrCbGaD
Methotrimeprazine—Constipation—Epirubicin—stomach cancer	0.000677	0.00161	CcSEcCtD
Methotrimeprazine—HRH1—lymph node—stomach cancer	0.000673	0.00535	CbGeAlD
Methotrimeprazine—Pipotiazine—HTR1A—stomach cancer	0.00067	0.0611	CrCbGaD
Methotrimeprazine—CYP2D6—liver—stomach cancer	0.000668	0.00531	CbGeAlD
Methotrimeprazine—Mesoridazine—HTR1A—stomach cancer	0.000661	0.0603	CrCbGaD
Methotrimeprazine—ADRA2A—lymph node—stomach cancer	0.000661	0.00526	CbGeAlD
Methotrimeprazine—Somnolence—Doxorubicin—stomach cancer	0.000651	0.00154	CcSEcCtD
Methotrimeprazine—Constipation—Doxorubicin—stomach cancer	0.000627	0.00149	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Methotrexate—stomach cancer	0.000623	0.00148	CcSEcCtD
Methotrimeprazine—Hypersensitivity—Epirubicin—stomach cancer	0.000583	0.00138	CcSEcCtD
Methotrimeprazine—Fluphenazine—HTR1A—stomach cancer	0.000579	0.0528	CrCbGaD
Methotrimeprazine—Hypersensitivity—Doxorubicin—stomach cancer	0.00054	0.00128	CcSEcCtD
Methotrimeprazine—Thioridazine—HTR1A—stomach cancer	0.000499	0.0455	CrCbGaD
Methotrimeprazine—Trimipramine—HTR1A—stomach cancer	0.000487	0.0444	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR1A—stomach cancer	0.000463	0.0422	CrCbGaD
Methotrimeprazine—Perphenazine—HTR1A—stomach cancer	0.000458	0.0418	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR1A—stomach cancer	0.000363	0.0331	CrCbGaD
Methotrimeprazine—Imipramine—HTR1A—stomach cancer	0.000361	0.033	CrCbGaD
Methotrimeprazine—Acepromazine—ALB—stomach cancer	0.000313	0.0285	CrCbGaD
Methotrimeprazine—Thioproperazine—ALB—stomach cancer	0.000306	0.0279	CrCbGaD
Methotrimeprazine—Pipotiazine—ALB—stomach cancer	0.000301	0.0274	CrCbGaD
Methotrimeprazine—Clomipramine—ALB—stomach cancer	0.000238	0.0217	CrCbGaD
Methotrimeprazine—Chlorpromazine—ALB—stomach cancer	0.000163	0.0149	CrCbGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	9.9e-06	2.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—HRAS—stomach cancer	9.9e-06	2.24e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK1—stomach cancer	9.89e-06	2.24e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—EGFR—stomach cancer	9.89e-06	2.24e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CXCL8—stomach cancer	9.87e-06	2.24e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	9.84e-06	2.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	9.82e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	9.81e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—HRAS—stomach cancer	9.8e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—KRAS—stomach cancer	9.8e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1B—stomach cancer	9.79e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	9.79e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	9.78e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK1—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—EGFR—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—EGFR—stomach cancer	9.76e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	9.75e-06	2.21e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1B—stomach cancer	9.73e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—stomach cancer	9.71e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—STAT3—stomach cancer	9.69e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	9.64e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1B—stomach cancer	9.64e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	9.61e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—stomach cancer	9.56e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—stomach cancer	9.54e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PIK3CA—stomach cancer	9.53e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCND1—stomach cancer	9.52e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—stomach cancer	9.51e-06	2.15e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—JUN—stomach cancer	9.5e-06	2.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—stomach cancer	9.48e-06	2.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PIK3CA—stomach cancer	9.4e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	9.4e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—stomach cancer	9.38e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCND1—stomach cancer	9.36e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—stomach cancer	9.36e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—JUN—stomach cancer	9.34e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCND1—stomach cancer	9.34e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—KRAS—stomach cancer	9.34e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—stomach cancer	9.34e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—JUN—stomach cancer	9.32e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCND1—stomach cancer	9.31e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—STAT3—stomach cancer	9.31e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—JUN—stomach cancer	9.29e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCND1—stomach cancer	9.28e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—JUN—stomach cancer	9.26e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	9.26e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—stomach cancer	9.24e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—stomach cancer	9.22e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—KRAS—stomach cancer	9.22e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—KRAS—stomach cancer	9.22e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CDKN1A—stomach cancer	9.21e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCND1—stomach cancer	9.19e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—JUN—stomach cancer	9.17e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCND1—stomach cancer	9.17e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—JUN—stomach cancer	9.15e-06	2.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	9.14e-06	2.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	9.14e-06	2.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—stomach cancer	9.1e-06	2.06e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—stomach cancer	9.09e-06	2.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	9.08e-06	2.06e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—stomach cancer	9.07e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	9.06e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—STAT3—stomach cancer	9.05e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—stomach cancer	9.04e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CDKN1A—stomach cancer	9.04e-06	2.05e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—stomach cancer	9.01e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	9.01e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PIK3CA—stomach cancer	9.01e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MYC—stomach cancer	9.01e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAV1—stomach cancer	9e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	9e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK8—stomach cancer	8.98e-06	2.04e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CDKN1A—stomach cancer	8.98e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOA1—stomach cancer	8.98e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	8.93e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—stomach cancer	8.93e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—STAT3—stomach cancer	8.91e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—stomach cancer	8.9e-06	2.02e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CDKN1A—stomach cancer	8.89e-06	2.01e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	8.89e-06	2.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	8.87e-06	2.01e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	8.84e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK8—stomach cancer	8.82e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HRAS—stomach cancer	8.82e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	8.81e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—EGFR—stomach cancer	8.81e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK8—stomach cancer	8.79e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK8—stomach cancer	8.77e-06	1.99e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—stomach cancer	8.71e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HRAS—stomach cancer	8.7e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—stomach cancer	8.69e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK8—stomach cancer	8.68e-06	1.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	8.66e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	8.65e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MYC—stomach cancer	8.65e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.6e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	8.58e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PIK3CA—stomach cancer	8.54e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCND1—stomach cancer	8.52e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	8.51e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—JUN—stomach cancer	8.5e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	8.47e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PIK3CA—stomach cancer	8.47e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	8.46e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—EGFR—stomach cancer	8.46e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—stomach cancer	8.44e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MYC—stomach cancer	8.41e-06	1.91e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ALB—stomach cancer	8.4e-06	1.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HRAS—stomach cancer	8.33e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—stomach cancer	8.33e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—KRAS—stomach cancer	8.32e-06	1.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—stomach cancer	8.3e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—stomach cancer	8.3e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MYC—stomach cancer	8.28e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—stomach cancer	8.27e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	8.24e-06	1.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	8.23e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—EGFR—stomach cancer	8.23e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—STAT3—stomach cancer	8.21e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—stomach cancer	8.19e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—stomach cancer	8.19e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	8.16e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—stomach cancer	8.15e-06	1.85e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—stomach cancer	8.12e-06	1.84e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	8.1e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—EGFR—stomach cancer	8.1e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—stomach cancer	8.09e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—STAT3—stomach cancer	8.08e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—STAT3—stomach cancer	8.07e-06	1.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	8.04e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—STAT3—stomach cancer	8.04e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—stomach cancer	8.03e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—stomach cancer	8.01e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—STAT3—stomach cancer	8.01e-06	1.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	7.99e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—KRAS—stomach cancer	7.99e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—stomach cancer	7.98e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HRAS—stomach cancer	7.94e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—STAT3—stomach cancer	7.94e-06	1.8e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—STAT3—stomach cancer	7.91e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—stomach cancer	7.91e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK3—stomach cancer	7.85e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HRAS—stomach cancer	7.83e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HRAS—stomach cancer	7.83e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—KRAS—stomach cancer	7.77e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	7.72e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK3—stomach cancer	7.71e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK3—stomach cancer	7.68e-06	1.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK3—stomach cancer	7.66e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—KRAS—stomach cancer	7.65e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	7.64e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MYC—stomach cancer	7.63e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—stomach cancer	7.6e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK3—stomach cancer	7.58e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	7.56e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PIK3CA—stomach cancer	7.56e-06	1.71e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MYC—stomach cancer	7.51e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—stomach cancer	7.5e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—stomach cancer	7.5e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MYC—stomach cancer	7.49e-06	1.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MYC—stomach cancer	7.47e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK1—stomach cancer	7.47e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—EGFR—stomach cancer	7.47e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MYC—stomach cancer	7.45e-06	1.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	7.43e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—stomach cancer	7.4e-06	1.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MYC—stomach cancer	7.37e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MYC—stomach cancer	7.35e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—STAT3—stomach cancer	7.35e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	7.35e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—stomach cancer	7.35e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—EGFR—stomach cancer	7.35e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	7.34e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK1—stomach cancer	7.33e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—EGFR—stomach cancer	7.33e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK1—stomach cancer	7.31e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—EGFR—stomach cancer	7.31e-06	1.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK1—stomach cancer	7.28e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—EGFR—stomach cancer	7.28e-06	1.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK1—stomach cancer	7.21e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—EGFR—stomach cancer	7.21e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	7.19e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—EGFR—stomach cancer	7.19e-06	1.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	7.14e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ALB—stomach cancer	7.11e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—stomach cancer	7.1e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HRAS—stomach cancer	7.07e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—KRAS—stomach cancer	7.05e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	7.03e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	7.03e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—KRAS—stomach cancer	6.94e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PIK3CA—stomach cancer	6.94e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—KRAS—stomach cancer	6.92e-06	1.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—stomach cancer	6.91e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—KRAS—stomach cancer	6.9e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—KRAS—stomach cancer	6.88e-06	1.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MYC—stomach cancer	6.83e-06	1.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—KRAS—stomach cancer	6.81e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—stomach cancer	6.81e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—stomach cancer	6.8e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—KRAS—stomach cancer	6.79e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HRAS—stomach cancer	6.79e-06	1.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—stomach cancer	6.77e-06	1.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	6.68e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—EGFR—stomach cancer	6.68e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HRAS—stomach cancer	6.61e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HRAS—stomach cancer	6.5e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—stomach cancer	6.5e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PIK3CA—stomach cancer	6.48e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	6.38e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PIK3CA—stomach cancer	6.37e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PIK3CA—stomach cancer	6.36e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	6.34e-06	1.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—stomach cancer	6.32e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PIK3CA—stomach cancer	6.32e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—KRAS—stomach cancer	6.31e-06	1.43e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—stomach cancer	6.27e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PIK3CA—stomach cancer	6.26e-06	1.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	6.24e-06	1.41e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—stomach cancer	6.22e-06	1.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—stomach cancer	6.22e-06	1.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—stomach cancer	6.17e-06	1.4e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—stomach cancer	6.15e-06	1.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—stomach cancer	6.13e-06	1.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—stomach cancer	6.12e-06	1.39e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—stomach cancer	6.06e-06	1.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—stomach cancer	6.04e-06	1.37e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HRAS—stomach cancer	5.99e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—HRAS—stomach cancer	5.9e-06	1.34e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HRAS—stomach cancer	5.89e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HRAS—stomach cancer	5.87e-06	1.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HRAS—stomach cancer	5.85e-06	1.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	5.8e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HRAS—stomach cancer	5.79e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HRAS—stomach cancer	5.78e-06	1.31e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—stomach cancer	5.74e-06	1.3e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—stomach cancer	5.65e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—stomach cancer	5.63e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—stomach cancer	5.62e-06	1.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—stomach cancer	5.61e-06	1.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—stomach cancer	5.6e-06	1.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—stomach cancer	5.54e-06	1.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—stomach cancer	5.53e-06	1.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HRAS—stomach cancer	5.37e-06	1.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—stomach cancer	5.14e-06	1.16e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3CA—stomach cancer	4.52e-06	1.02e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3CA—stomach cancer	3.83e-06	8.67e-06	CbGpPWpGaD
